GrB-Fc-KS49, an anti-EMP2 granzyme B fusion protein therapeutic alters immune cell infiltration and suppresses breast cancer growth.
Mohamedali KA, Aguirre B, Lu CH, Chandla A, Kejriwal N, Liu L, Chan AM, Cheung LH, Kok S, Duarte S, Alvarez de Cienfuegos A, Casero D, Rosenblum MG, Wadehra M.
Mohamedali KA, et al. Among authors: lu ch.
J Immunother Cancer. 2024 Dec 22;12(12):e008891. doi: 10.1136/jitc-2024-008891.
J Immunother Cancer. 2024.
PMID: 39794935
Free PMC article.